Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis (Q37404847)

20 August 2017

1 reference

title

Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis (English)

1 reference

20 August 2017

Bacillus anthracis

1 reference

based on heuristic

inferred from title

author name string

Jean-Nicolas Tournier

1

1 reference

20 August 2017

Robert G Ulrich

2

1 reference

20 August 2017

Anne Quesnel-Hellmann

3

1 reference

20 August 2017

Mansour Mohamadzadeh

4

1 reference

20 August 2017

Bradley G Stiles

5

1 reference

20 August 2017

1 March 2009

1 reference

Expert Review of Anti-infective Therapy

20 August 2017

1 reference

20 August 2017

7

1 reference

20 August 2017

2

1 reference

20 August 2017

219-236

1 reference

100th anniversary of Robert Koch's Nobel Prize for the discovery of the tubercle bacillus

20 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Anthrax vaccines: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Human live anthrax vaccine in the former USSR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Field Evaluation of a Human Anthrax Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Anthrax vaccine and public health policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Anthrax capsule vaccine protects against experimental infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Past, imminent and future human medical countermeasures for anthrax

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Vaccines: countering anthrax: vaccines and immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Bacillus anthracis multiplication, persistence, and genetic exchange in the rhizosphere of grass plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Poly-gamma-glutamate in bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Poly-gamma-glutamate capsule-degrading enzyme treatment enhances phagocytosis and killing of encapsulated Bacillus anthracis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Anthrax toxin: receptor binding, internalization, pore formation, and translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Anthrax as a biological weapon, 2002: updated recommendations for management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Observations on the prophylaxis of experimental pulmonary anthrax in the monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Quantitative pathology of inhalational anthrax I: quantitative microscopic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Pathology and pathogenesis of bioterrorism-related inhalational anthrax

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Primary involvement of pharynx and peyer's patch in inhalational and intestinal anthrax

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Detection of Bacillus anthracis spore germination in vivo by bioluminescence imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Anthrax lethal toxin impairs innate immune functions of alveolar macrophages and facilitates Bacillus anthracis survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Resident CD11c+ lung cells are impaired by anthrax toxins after spore infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Contribution of toxins to the pathogenesis of inhalational anthrax

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Antiinflammatory cAMP signaling and cell migration genes co-opted by the anthrax bacillus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

The crystal structure of the Bacillus anthracis spore surface protein BclA shows remarkable similarity to mammalian proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Bacillus anthracis spores of the bclA mutant exhibit increased adherence to epithelial cells, fibroblasts, and endothelial cells but not to macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Identification of the immunodominant protein and other proteins of the Bacillus anthracis exosporium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

A collagen-like surface glycoprotein is a structural component of the Bacillus anthracis exosporium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Saccharides cross-reactive with Bacillus anthracis spore glycoprotein as an anthrax vaccine component

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

The integrin Mac-1 (CR3) mediates internalization and directs Bacillus anthracis spores into professional phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Anthrax toxin: the long and winding road that leads to the kill

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Anthrax protective antigen cleavage and clearance from the blood of mice and rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Activity of the Bacillus anthracis 20 kDa protective antigen component

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Crystal structure of the anthrax toxin protective antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Involvement of residues 147VYYEIGK153 in binding of lethal factor to protective antigen of Bacillus anthracis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Stoichiometry of anthrax toxin complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Conformational fluctuations in anthrax protective antigen: a possible role of calcium in the folding pathway of the protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

A monoclonal antibody to Bacillus anthracis protective antigen defines a neutralizing epitope in domain 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Alanine-scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a neutralizing monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Identification of the cellular receptor for anthrax toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Crystal structure of a complex between anthrax toxin and its host cell receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Anthrax toxin receptor 2-dependent lethal toxin killing in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

A soluble receptor decoy protects rats against anthrax lethal toxin challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Characterization of the interaction between anthrax toxin and its cellular receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

LRP5 and LRP6 are not required for protective antigen-mediated internalization or lethality of anthrax lethal toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Evidence against a human cell-specific role for LRP6 in anthrax toxin entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Evidence that translocation of anthrax toxin's lethal factor is initiated by entry of its N terminus into the protective antigen channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Sizing the Bacillus anthracis PA63 channel with nonelectrolyte poly(ethylene glycols)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Acid-induced unfolding of the amino-terminal domains of the lethal and edema factors of anthrax toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Receptor-specific requirements for anthrax toxin delivery into cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Whole-cell voltage clamp measurements of anthrax toxin pore current

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Acid induced unfolding of anthrax protective antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Point mutations in anthrax protective antigen that block translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Trp 346 and Leu 352 residues in protective antigen are required for the expression of anthrax lethal toxin activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Gln277 and Phe554 residues are involved in thermal inactivation of protective antigen of Bacillus anthracis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

A phenylalanine clamp catalyzes protein translocation through the anthrax toxin pore

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Anthrax toxins: A paradigm of bacterial immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Crystal structure of the anthrax lethal factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Cell entry and cAMP imaging of anthrax edema toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Differentiation of human monocytic cell lines confers susceptibility to Bacillus anthracis lethal toxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Macrophage-derived cell lines do not express proinflammatory cytokines after exposure to Bacillus anthracis lethal toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Anthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Anthrax lethal toxin has direct and potent inhibitory effects on B cell proliferation and immunoglobulin production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Anthrax lethal toxin-mediated killing of human and murine dendritic cells impairs the adaptive immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Sensitizing anthrax lethal toxin-resistant macrophages to lethal toxin-induced killing by tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Anthrax lethal toxin and Salmonella elicit the common cell death pathway of caspase-1-dependent pyroptosis via distinct mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Maturation modulates caspase-1-independent responses of dendritic cells to Anthrax lethal toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Killing of macrophages by anthrax lethal toxin: involvement of the N-end rule pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Mitochondrial proteins Bnip3 and Bnip3L are involved in anthrax lethal toxin-induced macrophage cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Anthrax toxins induce shock in rats by depressed cardiac ventricular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Characterisation of adsorbed anthrax vaccine by two-dimensional gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Effect of aluminum hydroxide adjuvant and formaldehyde in the formulation of rPA anthrax vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Gorse GJ, et al. "Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial" [Vaccine 24 (2006) 5950-5959].

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

The potential of antibody-mediated immunity in the defence against biological weapons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Analysis of epitope information related to Bacillus anthracis and Clostridium botulinum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Immunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Antigen-specific CD4+ T cells recognize epitopes of protective antigen following vaccination with an anthrax vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Paratope diversity in the human antibody response to Bacillus anthracis protective antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Domain specificity of the human antibody response to Bacillus anthracis protective antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Search for correlates of protective immunity conferred by anthrax vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

In vitro correlate of immunity in a rabbit model of inhalational anthrax

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Protective antigen as a correlative marker for anthrax in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Noncapsulated toxinogenic Bacillus anthracis presents a specific growth and dissemination pattern in naive and protective antigen-immune mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Characterization of the human immune response to the UK anthrax vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Anthrax vaccine: short-term safety experience in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Patterns of antibody response in humans to the anthrax vaccine adsorbed (AVA) primary (six-dose) series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Duration of protection of rabbits after vaccination with Bacillus anthracis recombinant protective antigen vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Selection of a macaque Fab with framework regions like those in humans, high affinity, and ability to neutralize the protective antigen (PA) of Bacillus anthracis by binding to the segment of PA between residues 686 and 694.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Human antibodies from immunized donors are protective against anthrax toxin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Combining anthrax vaccine and therapy: a dominant-negative inhibitor of anthrax toxin is also a potent and safe immunogen for vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Recombinant exosporium protein BclA of Bacillus anthracis is effective as a booster for mice primed with suboptimal amounts of protective antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Immunogenicity and protective efficacy of Bacillus anthracis poly-gamma-D-glutamic acid capsule covalently coupled to a protein carrier using a novel triazine-based conjugation strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

The perfect mix: recent progress in adjuvant research

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Targeting the innate immune response with improved vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

CpG oligonucleotides accelerate and boost the immune response elicited by AVA, the licensed anthrax vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Systemic but not mucosal immunity induced by AVA prevents inhalational anthrax

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Investigation in a model system of the effects of combinations of anthrax and pertussis vaccines administered to service personnel in the 1991 Gulf War.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Bacillus anthracis edema toxin acts as an adjuvant for mucosal immune responses to nasally administered vaccine antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Evidence for adjuvanticity of anthrax edema toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Mucosal immunity and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Microenvironmental impact on lung cell homeostasis and immunity during infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Vaccination to prevent herpes zoster and postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Oral spore vaccine based on live attenuated nontoxinogenic Bacillus anthracis expressing recombinant mutant protective antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Targeting mucosal dendritic cells with microbial antigens from probiotic lactic acid bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

MMDB: Entrez's 3D-structure database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Protein Translocation through the Anthrax Toxin Transmembrane Pore is Driven by a Proton Gradient

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Dominant-Negative Mutants of a Toxin Subunit: An Approach to Therapy of Anthrax

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

pH-dependent permeabilization of the plasma membrane of mammalian cells by anthrax protective antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

Immunization against anthrax using Bacillus subtilis spores expressing the anthrax protective antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.219

21 January 2018

Identifiers

DOI

10.1586/14787210.7.2.219

1 reference

20 August 2017

1 reference